{"id":206387,"date":"2021-01-11T19:35:50","date_gmt":"2021-01-11T12:35:50","guid":{"rendered":"https:\/\/setkab.go.id\/?p=206387"},"modified":"2021-01-12T21:59:57","modified_gmt":"2021-01-12T14:59:57","slug":"bpom-issues-eua-for-sinovac-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/","title":{"rendered":"BPOM Issues EUA for Sinovac COVID-19 Vaccine"},"content":{"rendered":"<div id=\"attachment_206388\" style=\"width: 1450px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-206388\" class=\"size-full wp-image-206388\" src=\"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png\" alt=\"\" width=\"1440\" height=\"809\" srcset=\"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png 1440w, https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1-300x169.png 300w, https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1-1024x575.png 1024w, https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1-768x431.png 768w, https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1-600x337.png 600w, https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1-700x393.png 700w, https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1-360x202.png 360w\" sizes=\"auto, (max-width: 1440px) 100vw, 1440px\" \/><p id=\"caption-attachment-206388\" class=\"wp-caption-text\">Head of the BPOM Penny Lukito gives a press statement in Jakarta, Monday (11\/01). (Source: BPOM RI YouTube)<\/p><\/div>\n<p>The Food and Drugs Monitoring Agency (BPOM) has officially issued the EUA (Emergency Use Authorization) for CoronaVac, a COVID-19 vaccine developed by China&#8217;s Sinovac Biotech.<\/p>\n<p>&#8220;The results of clinical trials show that CoronaVac is safe with mild to moderate side effects, including local side effects such as pain, induration, redness, and swelling as well as systemic side effects such as myalgia, fatigue, and fever,&#8221; Head of the BPOM Penny Lukito stated during a press conference via BPOM RI\u2019s YouTube channel, Monday (11\/01).<\/p>\n<p>These side effects, she added, are not dangerous.<\/p>\n<p>Head of the BPOM said that the results of clinical trials for the safety of CoronaVac are obtained from phase three clinical studies in Indonesia, Turkey, and Brazil which were monitored for a period of 3 months after injection of the second dose.<\/p>\n<p>The vaccine, she said, has shown its ability to produce an antibody that has the ability to kill or neutralize the viruses (immunogenicity), as seen from phase 1 and 2 clinical trials in China with a monitoring period of up to 6 months.<\/p>\n<p>&#8220;In phase 3 clinical trial in Bandung, immunogenicity data showed good results. Up to 3 months, the number of subjects who has antibodies is still high, namely 99.23 percent,&#8221; she stated.<\/p>\n<p>In addition, an analysis of the efficacy of CoronaVac from phase three clinical trials shows that the vaccine has met the WHO\u2019s requirement of a minimum 50 percent efficacy. The results of clinical trial in Bandung demonstrate a 65.3 percent efficacy, while similar trial in Turkey demonstrates a 91.25 percent efficacy, and 78 percent for trial in Brazil.<\/p>\n<p>&#8220;The vaccine&#8217;s efficacy of 65.3 percent from the results of clinical trial in Bandung shows hope that this vaccine is able to reduce the COVID-19 contraction by 65.3 percent,&#8221; Penny said.<\/p>\n<p>To ensure the vaccine\u2019s quality, the BPOM has also conducted an evaluation of vaccine quality data, which includes supervision starting from raw materials, manufacturing processes to finished vaccine products in accordance with internationally accepted vaccine quality assessment standards.<\/p>\n<p>The decision to issue the EUA was based on comprehensive evaluation and discussion on supporting data and scientific evidence that supports the safety, efficacy, and quality aspects of vaccines.<\/p>\n<p>Penny further said that the Agency always prioritizes prudence, integrity, and independence, as well as transparency in making this decision in order to protect public health.<\/p>\n<p>&#8220;Let&#8217;s support the COVID-19 vaccination program, because the success of COVID-19 handling is our success as a nation,&#8221; she stated.\u00a0<strong>(PR of BPOM\/UN)<\/strong> <strong>(FI\/MMB) \u00a0\u00a0<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Food and Drugs Monitoring Agency (BPOM) has officially issued the EUA (Emergency Use Authorization) for CoronaVac, a COVID-19 vaccine developed by China&#8217;s Sinovac Biotech. &#8220;The results of clinical trials show that CoronaVac is safe with mild to moderate side effects, including local side effects such as pain, induration, redness, and swelling as well as [&hellip;]<\/p>\n","protected":false},"author":43,"featured_media":206388,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[77,66],"tags":[],"class_list":["post-206387","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-uncategorized-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.1 (Yoast SEO v26.1.1) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BPOM Issues EUA for Sinovac COVID-19 Vaccine - Sekretariat Kabinet Republik Indonesia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BPOM Issues EUA for Sinovac COVID-19 Vaccine - Sekretariat Kabinet Republik Indonesia\" \/>\n<meta property=\"og:description\" content=\"The Food and Drugs Monitoring Agency (BPOM) has officially issued the EUA (Emergency Use Authorization) for CoronaVac, a COVID-19 vaccine developed by China&#8217;s Sinovac Biotech. &#8220;The results of clinical trials show that CoronaVac is safe with mild to moderate side effects, including local side effects such as pain, induration, redness, and swelling as well as [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"Sekretariat Kabinet Republik Indonesia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/id-id.facebook.com\/Setkabgoid\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-11T12:35:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-01-12T14:59:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"809\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Office of Assistant to Deputy Cabinet Secretary for State Documents &amp; Translation\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@setkabgoid\" \/>\n<meta name=\"twitter:site\" content=\"@setkabgoid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Office of Assistant to Deputy Cabinet Secretary for State Documents &amp; Translation\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/\"},\"author\":{\"name\":\"Office of Assistant to Deputy Cabinet Secretary for State Documents &amp; Translation\",\"@id\":\"https:\/\/setkab.go.id\/#\/schema\/person\/ccc9c04099be79c6aa9ed45cb3bf345e\"},\"headline\":\"BPOM Issues EUA for Sinovac COVID-19 Vaccine\",\"datePublished\":\"2021-01-11T12:35:50+00:00\",\"dateModified\":\"2021-01-12T14:59:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/\"},\"wordCount\":438,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/setkab.go.id\/#organization\"},\"image\":{\"@id\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png\",\"articleSection\":[\"News\",\"Uncategorized @en\"],\"inLanguage\":\"ENH\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/\",\"url\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/\",\"name\":\"BPOM Issues EUA for Sinovac COVID-19 Vaccine - Sekretariat Kabinet Republik Indonesia\",\"isPartOf\":{\"@id\":\"https:\/\/setkab.go.id\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png\",\"datePublished\":\"2021-01-11T12:35:50+00:00\",\"dateModified\":\"2021-01-12T14:59:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#breadcrumb\"},\"inLanguage\":\"ENH\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ENH\",\"@id\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#primaryimage\",\"url\":\"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png\",\"contentUrl\":\"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png\",\"width\":1440,\"height\":809,\"caption\":\"Head of the BPOM Penny Lukito gives a press statement in Jakarta, Monday (11\/01). (Source: BPOM RI YouTube)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/setkab.go.id\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BPOM Issues EUA for Sinovac COVID-19 Vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/setkab.go.id\/#website\",\"url\":\"https:\/\/setkab.go.id\/\",\"name\":\"Sekretariat Kabinet Republik Indonesia\",\"description\":\"Kabinet Merah Putih\",\"publisher\":{\"@id\":\"https:\/\/setkab.go.id\/#organization\"},\"alternateName\":\"Setkab\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/setkab.go.id\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ENH\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/setkab.go.id\/#organization\",\"name\":\"Sekretariat Kabinet\",\"alternateName\":\"Setkab\",\"url\":\"https:\/\/setkab.go.id\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ENH\",\"@id\":\"https:\/\/setkab.go.id\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/setkab.go.id\/wp-content\/uploads\/2020\/05\/garuda.png\",\"contentUrl\":\"https:\/\/setkab.go.id\/wp-content\/uploads\/2020\/05\/garuda.png\",\"width\":720,\"height\":788,\"caption\":\"Sekretariat Kabinet\"},\"image\":{\"@id\":\"https:\/\/setkab.go.id\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/id-id.facebook.com\/Setkabgoid\",\"https:\/\/x.com\/setkabgoid\",\"https:\/\/www.instagram.com\/sekretariat.kabinet\/\",\"https:\/\/www.youtube.com\/channel\/UCey1BgbIUz6eVz2vywc2d7g\",\"https:\/\/id.wikipedia.org\/wiki\/Sekretariat_Kabinet_Republik_Indonesia\",\"https:\/\/www.tiktok.com\/@setkabgoid\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/setkab.go.id\/#\/schema\/person\/ccc9c04099be79c6aa9ed45cb3bf345e\",\"name\":\"Office of Assistant to Deputy Cabinet Secretary for State Documents &amp; Translation\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ENH\",\"@id\":\"https:\/\/setkab.go.id\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8238a2781f78eec52de6cbadf268cdcab6067d59123790258ac87c2b257c0b3f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8238a2781f78eec52de6cbadf268cdcab6067d59123790258ac87c2b257c0b3f?s=96&d=mm&r=g\",\"caption\":\"Office of Assistant to Deputy Cabinet Secretary for State Documents &amp; Translation\"},\"sameAs\":[\"http:\/\/www.setkab.go.id\"],\"url\":\"https:\/\/setkab.go.id\/en\/author\/naster\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BPOM Issues EUA for Sinovac COVID-19 Vaccine - Sekretariat Kabinet Republik Indonesia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/","og_locale":"en_US","og_type":"article","og_title":"BPOM Issues EUA for Sinovac COVID-19 Vaccine - Sekretariat Kabinet Republik Indonesia","og_description":"The Food and Drugs Monitoring Agency (BPOM) has officially issued the EUA (Emergency Use Authorization) for CoronaVac, a COVID-19 vaccine developed by China&#8217;s Sinovac Biotech. &#8220;The results of clinical trials show that CoronaVac is safe with mild to moderate side effects, including local side effects such as pain, induration, redness, and swelling as well as [&hellip;]","og_url":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/","og_site_name":"Sekretariat Kabinet Republik Indonesia","article_publisher":"https:\/\/id-id.facebook.com\/Setkabgoid","article_published_time":"2021-01-11T12:35:50+00:00","article_modified_time":"2021-01-12T14:59:57+00:00","og_image":[{"width":1440,"height":809,"url":"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png","type":"image\/png"}],"author":"Office of Assistant to Deputy Cabinet Secretary for State Documents &amp; Translation","twitter_card":"summary_large_image","twitter_creator":"@setkabgoid","twitter_site":"@setkabgoid","twitter_misc":{"Written by":"Office of Assistant to Deputy Cabinet Secretary for State Documents &amp; Translation","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#article","isPartOf":{"@id":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/"},"author":{"name":"Office of Assistant to Deputy Cabinet Secretary for State Documents &amp; Translation","@id":"https:\/\/setkab.go.id\/#\/schema\/person\/ccc9c04099be79c6aa9ed45cb3bf345e"},"headline":"BPOM Issues EUA for Sinovac COVID-19 Vaccine","datePublished":"2021-01-11T12:35:50+00:00","dateModified":"2021-01-12T14:59:57+00:00","mainEntityOfPage":{"@id":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/"},"wordCount":438,"commentCount":0,"publisher":{"@id":"https:\/\/setkab.go.id\/#organization"},"image":{"@id":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#primaryimage"},"thumbnailUrl":"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png","articleSection":["News","Uncategorized @en"],"inLanguage":"ENH","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/","url":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/","name":"BPOM Issues EUA for Sinovac COVID-19 Vaccine - Sekretariat Kabinet Republik Indonesia","isPartOf":{"@id":"https:\/\/setkab.go.id\/#website"},"primaryImageOfPage":{"@id":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#primaryimage"},"image":{"@id":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#primaryimage"},"thumbnailUrl":"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png","datePublished":"2021-01-11T12:35:50+00:00","dateModified":"2021-01-12T14:59:57+00:00","breadcrumb":{"@id":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#breadcrumb"},"inLanguage":"ENH","potentialAction":[{"@type":"ReadAction","target":["https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/"]}]},{"@type":"ImageObject","inLanguage":"ENH","@id":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#primaryimage","url":"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png","contentUrl":"https:\/\/setkab.go.id\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-11-at-16.17.53-1.png","width":1440,"height":809,"caption":"Head of the BPOM Penny Lukito gives a press statement in Jakarta, Monday (11\/01). (Source: BPOM RI YouTube)"},{"@type":"BreadcrumbList","@id":"https:\/\/setkab.go.id\/en\/bpom-issues-eua-for-sinovac-covid-19-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/setkab.go.id\/en\/"},{"@type":"ListItem","position":2,"name":"BPOM Issues EUA for Sinovac COVID-19 Vaccine"}]},{"@type":"WebSite","@id":"https:\/\/setkab.go.id\/#website","url":"https:\/\/setkab.go.id\/","name":"Sekretariat Kabinet Republik Indonesia","description":"Kabinet Merah Putih","publisher":{"@id":"https:\/\/setkab.go.id\/#organization"},"alternateName":"Setkab","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/setkab.go.id\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ENH"},{"@type":"Organization","@id":"https:\/\/setkab.go.id\/#organization","name":"Sekretariat Kabinet","alternateName":"Setkab","url":"https:\/\/setkab.go.id\/","logo":{"@type":"ImageObject","inLanguage":"ENH","@id":"https:\/\/setkab.go.id\/#\/schema\/logo\/image\/","url":"https:\/\/setkab.go.id\/wp-content\/uploads\/2020\/05\/garuda.png","contentUrl":"https:\/\/setkab.go.id\/wp-content\/uploads\/2020\/05\/garuda.png","width":720,"height":788,"caption":"Sekretariat Kabinet"},"image":{"@id":"https:\/\/setkab.go.id\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/id-id.facebook.com\/Setkabgoid","https:\/\/x.com\/setkabgoid","https:\/\/www.instagram.com\/sekretariat.kabinet\/","https:\/\/www.youtube.com\/channel\/UCey1BgbIUz6eVz2vywc2d7g","https:\/\/id.wikipedia.org\/wiki\/Sekretariat_Kabinet_Republik_Indonesia","https:\/\/www.tiktok.com\/@setkabgoid"]},{"@type":"Person","@id":"https:\/\/setkab.go.id\/#\/schema\/person\/ccc9c04099be79c6aa9ed45cb3bf345e","name":"Office of Assistant to Deputy Cabinet Secretary for State Documents &amp; Translation","image":{"@type":"ImageObject","inLanguage":"ENH","@id":"https:\/\/setkab.go.id\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8238a2781f78eec52de6cbadf268cdcab6067d59123790258ac87c2b257c0b3f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8238a2781f78eec52de6cbadf268cdcab6067d59123790258ac87c2b257c0b3f?s=96&d=mm&r=g","caption":"Office of Assistant to Deputy Cabinet Secretary for State Documents &amp; Translation"},"sameAs":["http:\/\/www.setkab.go.id"],"url":"https:\/\/setkab.go.id\/en\/author\/naster\/"}]}},"_links":{"self":[{"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/posts\/206387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/comments?post=206387"}],"version-history":[{"count":1,"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/posts\/206387\/revisions"}],"predecessor-version":[{"id":206389,"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/posts\/206387\/revisions\/206389"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/media\/206388"}],"wp:attachment":[{"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/media?parent=206387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/categories?post=206387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/setkab.go.id\/en\/api\/wp\/v2\/tags?post=206387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}